Stockscreener 앱 받기
3.21
2.13%
-0.07
시간 외 거래:
3.39
0.18
+5.61%
Macrogenics Inc 주식(MGNX)의 최신 뉴스
MacroGenics, Inc. (NASDAQ:MGNX) Receives Average Rating of "Hold" from Analysts - MarketBeat
MacroGenics' SWOT analysis: biotech stock faces pipeline hurdles amid cash strength - Investing.com India
MacroGenics downgraded to market perform by JMP, price target removed - MSN
FY2024 Earnings Estimate for MacroGenics Issued By B. Riley - MarketBeat
StockNews.com Upgrades MacroGenics (NASDAQ:MGNX) to Buy - MarketBeat
MacroGenics FY2024 EPS Estimate Increased by HC Wainwright - MarketBeat
Leerink Partnrs Increases Earnings Estimates for MacroGenics - MarketBeat
MacroGenics puts the brakes on vobra duo development - The Pharma Letter
MacroGenics downgraded to Market Perform from Outperform at JMP Securities - TipRanks
Peeling Back The Layers: Exploring Macrogenics Through Analyst Insights - Benzinga
MacroGenics, Inc. (NASDAQ:MGNX) Q2 2024 Earnings Call Transcript - Insider Monkey
MacroGenics (NASDAQ:MGNX) Rating Lowered to "Market Perform" at JMP Securities - MarketBeat
MacroGenics Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
MacroGenics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewswire
MacroGenics (MGNX) to Present at Guggenheim and Stifel Healthcare Conferences | MGNX Stock News - StockTitan
Earnings call: MacroGenics reports a revenue jump to $110.7 million By Investing.com - Investing.com South Africa
Earnings call: MacroGenics reports a revenue jump to $110.7 million - Investing.com India
MacroGenics Margenza rights sale a positive, says Leerink - TipRanks
MacroGenics (NASDAQ:MGNX) Receives Neutral Rating from HC Wainwright - MarketBeat
MacroGenics Inc earnings beat by $0.69, revenue topped estimates - Investing.com Australia
Macrogenics Inc (MGNX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Developments - GuruFocus.com
MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results - GlobeNewswire
MacroGenics Inc. Reports Strong Revenue Growth - TipRanks
MacroGenics: Q3 Earnings Snapshot - Barchart
MacroGenics (MGNX) Q3 2024 Earnings Call Transcript - Nasdaq
Here's What Key Metrics Tell Us About MacroGenics (MGNX) Q3 Earnings - Yahoo Finance
MacroGenics (MGNX) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance
MacroGenics Q3 2024 Earnings Preview - MSN
Scott Koenig Intends to Step Down as Chief Executive Officer of MacroGenics, Inc., Effective February 28, 2025 - Marketscreener.com
Q3 2024 MacroGenics Inc Earnings Call Transcript - GuruFocus.com
Macrogenics Earnings Preview - Benzinga
Earnings To Watch: Macrogenics Inc (MGNX) Reports Q3 2024 Result - GuruFocus.com
MacroGenics (NASDAQ:MGNX) Lowered to Sell Rating by StockNews.com - MarketBeat
Masashi Miyamoto to become chairman and CEO of Kyowa Kirin - BioCentury
MacroGenics CEO Scott Koenig to resign early next year - Investing.com India
MacroGenics Announces Leadership Transition - GlobeNewswire
MacroGenics (MGNX) Scheduled to Post Earnings on Tuesday - MarketBeat
MacroGenics Co-Founder Koenig Stepping Down as President, CEO - MarketWatch
MacroGenics CEO Scott Koenig to resign early next year By Investing.com - Investing.com UK
Scott Koenig Intends to Step Down as Chief Executive Officer of MacroGenics, Inc., Early Next Year - Marketscreener.com
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call - GlobeNewswire
0.93%
3.55%
자본화:
|
볼륨(24시간):